Key facts
- This page summarizes Matthew Ros's Form 4 filing for Cogent Biosciences, Inc. (COGT).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 05 Jul 2022, 13:51.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.